Yvette N. Lamb

Yvette N. Lamb

Mairangi Bay, AUK 0754, New Zealand

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 77 publications

Sepiapterin: First Approval.

Sepiapterin: First Approval.

Journal: Drugs
Published: August 07, 2025

Recaticimab: First Approval.

Recaticimab: First Approval.

Journal: Drugs
Published: May 13, 2025

Tiratricol: First Approval.

Tiratricol: First Approval.

Journal: Drugs
Published: May 04, 2025

Tasurgratinib Succinate: First Approval.

Tasurgratinib Succinate: First Approval.

Journal: Drugs
Published: January 24, 2025

Correction: Fulzerasib: First Approval.

Correction: Fulzerasib: First Approval.

Journal: Drugs
Published: January 06, 2025

Marstacimab: First Approval.

Marstacimab: First Approval.

Journal: Drugs
Published: November 19, 2024

Correction: Vorasidenib: First Approval.

Correction: Vorasidenib: First Approval.

Journal: Drugs
Published: November 14, 2024

Fulzerasib: First Approval.

Fulzerasib: First Approval.

Journal: Drugs
Published: October 30, 2024

Vorasidenib: First Approval.

Vorasidenib: First Approval.

Journal: Drugs
Published: September 11, 2024

Givinostat: First Approval.

Givinostat: First Approval.

Journal: Drugs
Published: May 20, 2024

Correction to: Viloxazine: Pediatric First Approval.

Correction to: Viloxazine: Pediatric First Approval.

Journal: Paediatric drugs
Published: October 20, 2023

Correction to: Eftrenonacog Alfa: A Review in Haemophilia B.

Correction to: Eftrenonacog Alfa: A Review in Haemophilia B.

Journal: Drugs
Published: May 24, 2023
Showing 1-12 of 77

Last Updated: 09/26/2026